[37], which demonstrated that decitabine, an inhibitor of DNA methyltransferase 1 (DNMT1) suppresses the proliferation of IDH‐mutant glioma cells both in vitro and in vivo. The gene discussed is DNMT1; the disease is central nervous system cancer.